328 related articles for article (PubMed ID: 25031340)
21. M6PR interacts with the HA2 subunit of influenza A virus to facilitate the fusion of viral and endosomal membranes.
Hu Y; Jiang L; Wang G; Song Y; Shan Z; Wang X; Deng G; Shi J; Tian G; Zeng X; Liu L; Chen H; Li C
Sci China Life Sci; 2024 Mar; 67(3):579-595. PubMed ID: 38038885
[TBL] [Abstract][Full Text] [Related]
22. Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin-mediated vesicular trafficking pathway.
Thottasseri AA; Kaur G; Ramesh D; Banerjee I; Kannan T
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300670. PubMed ID: 38487979
[TBL] [Abstract][Full Text] [Related]
23. The Immunomodulatory CEA Cell Adhesion Molecule 6 (CEACAM6/CD66c) Is a Protein Receptor for the Influenza a Virus.
Rahman SK; Ansari MA; Gaur P; Ahmad I; Chakravarty C; Verma DK; Sharma A; Chhibber S; Nehal N; Wirth D; Lal SK
Viruses; 2021 Apr; 13(5):. PubMed ID: 33919410
[TBL] [Abstract][Full Text] [Related]
24. The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A Virus.
Ng WC; Londrigan SL; Nasr N; Cunningham AL; Turville S; Brooks AG; Reading PC
J Virol; 2016 Jan; 90(1):206-21. PubMed ID: 26468543
[TBL] [Abstract][Full Text] [Related]
25. Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.
Wang S; Chi X; Wei H; Chen Y; Chen Z; Huang S; Chen JL
J Virol; 2014 Aug; 88(15):8375-85. PubMed ID: 24829357
[TBL] [Abstract][Full Text] [Related]
26. Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza.
Günther SC; Martínez-Romero C; Sempere Borau M; Pham CTN; García-Sastre A; Stertz S
Microbiol Spectr; 2022 Aug; 10(4):e0092122. PubMed ID: 35867415
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetration.
Meier R; Franceschini A; Horvath P; Tetard M; Mancini R; von Mering C; Helenius A; Lozach PY
J Virol; 2014 Aug; 88(15):8565-78. PubMed ID: 24850728
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection.
Del Sarto J; Gerlt V; Friedrich ME; Anhlan D; Wixler V; Teixeira MM; Boergeling Y; Ludwig S
J Virol; 2021 Sep; 95(20):e0067221. PubMed ID: 34319782
[TBL] [Abstract][Full Text] [Related]
29. Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein.
Beyleveld G; Chin DJ; Moreno Del Olmo E; Carter J; Najera I; Cillóniz C; Shaw ML
mSphere; 2018 Nov; 3(6):. PubMed ID: 30429226
[TBL] [Abstract][Full Text] [Related]
30. Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication.
Berri F; Haffar G; Lê VB; Sadewasser A; Paki K; Lina B; Wolff T; Riteau B
J Virol; 2014 Oct; 88(19):11215-28. PubMed ID: 25031344
[TBL] [Abstract][Full Text] [Related]
31. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
[TBL] [Abstract][Full Text] [Related]
32. Correlative Light and Electron Microscopy of Influenza Virus Entry and Budding.
Hodgson L; Verkade P; Yamauchi Y
Methods Mol Biol; 2018; 1836():237-260. PubMed ID: 30151577
[TBL] [Abstract][Full Text] [Related]
33. Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus.
Gao Q; Yang C; Ren C; Zhang S; Gao X; Jin M; Chen H; Ma W; Zhou H
J Virol; 2020 Dec; 95(2):. PubMed ID: 33087462
[TBL] [Abstract][Full Text] [Related]
34. Role of TSPAN9 in Alphavirus Entry and Early Endosomes.
Stiles KM; Kielian M
J Virol; 2016 May; 90(9):4289-97. PubMed ID: 26865714
[TBL] [Abstract][Full Text] [Related]
35. Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication.
Mayank AK; Sharma S; Nailwal H; Lal SK
Cell Death Dis; 2015 Dec; 6(12):e2018. PubMed ID: 26673663
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a crucial role of a host non-coding RNA in influenza A virus replication.
Winterling C; Koch M; Koeppel M; Garcia-Alcalde F; Karlas A; Meyer TF
RNA Biol; 2014; 11(1):66-75. PubMed ID: 24440876
[TBL] [Abstract][Full Text] [Related]
37. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.
Chen SC; Jeng KS; Lai MMC
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860
[TBL] [Abstract][Full Text] [Related]
38. Influenza A Virus: Cellular Entry.
Miyake Y; Hara Y; Umeda M; Banerjee I
Subcell Biochem; 2023; 106():387-401. PubMed ID: 38159235
[TBL] [Abstract][Full Text] [Related]
39. Influenza A Virus Dysregulates Host Histone Deacetylase 1 That Inhibits Viral Infection in Lung Epithelial Cells.
Nagesh PT; Husain M
J Virol; 2016 May; 90(9):4614-4625. PubMed ID: 26912629
[TBL] [Abstract][Full Text] [Related]
40. Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
Wang B; Lam TH; Soh MK; Ye Z; Chen J; Ren EC
Front Immunol; 2018; 9():1193. PubMed ID: 29904383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
